Financially troubled Magna-Lab has ceased operations and has vacated its Edgewood, NY, manufacturing and office facility. Negotiations are under way to sell the developer of niche MRI scanners, according to vice president of marketing John Haytaian.The
Financially troubled Magna-Lab has ceased operations and has vacated its Edgewood, NY, manufacturing and office facility. Negotiations are under way to sell the developer of niche MRI scanners, according to vice president of marketing John Haytaian.
The company's status began unraveling this year when manufacturing operations were halted and 16 of 21 employees were laid off at the end of March, Haytaian said (SCAN 4/2/97). Most of the company's remaining business is handled by CEO Lawrence Minkoff and CFO Kenneth Riscica. Minkoff did not respond to phone calls.
According to a report filed with the Securities and Exchange Commission in April, the company adopted a restructuring plan that calls for the elimination of production, marketing, and some system engineering capability by strengthening its existing relationship with Elscint Cryomagnetics. Magna-Lab was notified by Elscint that if the Elscint proposal was not finalized by May 30, Elscint could seek to terminate the relationship. The two companies signed an agreement in June 1996, giving Elscint the exclusive right to market Magna-Lab's Magna-SL dedicated extremity MR scanner in certain international markets. Elscint was also expected to manufacture the 0.4-tesla system at its Fort Collins, CO, plant. Negotiations to finalize details of the agreement continued into March.
The Elscint agreement was still in place as of June 20, according to Haytaian. But more discussion is needed to work out how the relationship will proceed given that Magna-Lab is no longer manufacturing.
"Things are different in that Magna-Lab may take a different form going into the future," he said.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.